FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer

Investigational New Drugs

Volumn 28, Issue 3, 2010, Pages 234-241

  Wang, Feng ^a   Ezell, Scharri J ^a   Zhang, Yong ^d   Wang, Wei ^a   Rayburn, Elizabeth R ^a,b   Nadkarni, Dwayaja H ^c   Murugesan, Srinivasan ^c   Velu, Sadanandan E ^c   Zhang, Ruiwen ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Cell cycle; Chemotherapy; Makaluvamine; Prostate cancer

Indexed keywords

7 (4 FLUOROBENZYLAMINO) 1,3,4,8 TETRAHYDROPYRROLO[4,3,2 DE]QUINOLIN 8(1H) ONE; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PYRROLES; QUINOLONES; RECEPTORS, ANDROGEN;

EID: 77952240318     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-009-9232-x     Document Type: Article

References (28)

1. American Cancer Society, Inc. Leading Sites of New Cancer Cases and Deaths-2007 Estimates. Surveillance Research. 2007. Available online. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf. Accessed 9 December 2008
2. DI Quinn SM Henshall RL Sutherland 2005 Molecular markers of prostate cancer outcome Eur J Cancer 41 858 887 10.1016/j.ejca.2004.12.035 1:CAS:528:DC%2BD2MXjt1Wrtb4%3D 15808955 doi:10.1016/j.ejca.2004.12.035 (Pubitemid 40461690)
3. DP Petrylak 2005 The current role of chemotherapy in metastatic hormone-refractory prostate cancer Urology 65 3 7 10.1016/j.urology.2005.03.053 15885271 doi:10.1016/j.urology.2005.03.053 (Pubitemid 40693242)
4. T Tammela 2004 Endocrine treatment of prostate cancer J Steroid Biochem Mol Biol 92 287 295 10.1016/j.jsbmb.2004.10.005 1:CAS:528:DC%2BD2MXkvVShsg%3D%3D 15663992 doi:10.1016/j.jsbmb.2004.10.005 (Pubitemid 40128250)
5. B Haefner 2003 Drugs from the deep: marine natural products as drug candidates Drug Discov Today 8 536 544 10.1016/S1359-6446(03)02713-2 1:CAS:528:DC%2BD3sXkvVCntbw%3D 12821301 doi:10.1016/S1359-6446(03)02713-2 (Pubitemid 36773671)
6. JW Blunt BR Copp MH Munro, et al. 2006 Marine natural compounds Nat Prod Rep 23 26 78 10.1039/b502792f 1:CAS:528:DC%2BD28XitFykt78%3D 16453031 doi:10.1039/b502792f
7. E Marris 2006 Marine natural products: drugs from the deep Nature 443 904 905 10.1038/443904a 1:CAS:528:DC%2BD28XhtFaksrzO 17066005 doi:10.1038/443904a (Pubitemid 44646148)
8. G Schwartsmann A Brondani da Rocha RG Berlinck J Jimeno 2001 Marine organisms as a source of new anticancer agents Lancet Oncol 2 221 225 10.1016/S1470-2045(00)00292-8 1:CAS:528:DC%2BD3MXjvVarsr0%3D 11905767 doi:10.1016/S1470-2045(00)00292-8 (Pubitemid 33585934)
9. MG Dijoux WR Gamble YF Hallock JH Cardellina R van Soest MR Boyd 1999 A new discorhabdin from two sponge genera J Nat Prod 62 636 637 10.1021/np980465r 1:CAS:528:DyaK1MXhvFSjs7c%3D 10217730 doi:10.1021/np980465r (Pubitemid 29200755)
10. JR Carney PJ Scheuer M Kelly-Borges 1993 A new bastadin from the sponge Psammaplysilla purpurea J Nat Prod 56 153 157 10.1021/np50091a025 1:CAS:528:DyaK3sXhsVekt7Y%3D 8383731 doi:10.1021/np50091a025
11. A Casapullo A Cutignano I Bruno, et al. 2001 Makaluvamine P, a new cytotoxic pyrroloiminoquinone from Zyzzya cf. fuliginosa J Nat Prod 64 1354 1356 10.1021/np010053+ 1:CAS:528:DC%2BD3MXnt1Wrurs%3D 11678667 doi:10.1021/np010053+ (Pubitemid 33029223)
12. D Sipkema MC Franssen R Osinga J Tramper RH Wijffels 2005 Marine sponges as pharmacy Mar Biotechnol 7 142 162 10.1007/s10126-004-0405-5 1:CAS:528:DC%2BD2MXntFCiurY%3D 15776313 doi:10.1007/s10126-004-0405-5 (Pubitemid 41187741)
13. BA Shinkre KP Raisch L Fan SE Velu 2007 Analogs of the marine alkaloid makaluvamines: synthesis, topoisomerase II inhibition, and anticancer activity Bioorg Med Chem Lett 17 2890 2893 10.1016/j.bmcl.2007.02.065 1:CAS:528:DC%2BD2sXkslyjs7w%3D 17368022 doi:10.1016/j.bmcl.2007.02.065 (Pubitemid 46636250)
14. SE Velu SK Pillai MV Lakshmikantham AD Billimoria JS Culpepper MP Cava 1995 Efficient syntheses of the marine alkaloids makaluvamine D and discorhabdin C: the 4,6,7-trimethoxyindole approach J Org Chem 60 1800 1805 10.1021/jo00111a043 doi:10.1021/jo00111a043
15. BA Shinkre KP Raisch L Fan SE Velu 2008 Synthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvamines Bioorg Med Chem 16 2541 2549 10.1016/j.bmc.2007.11.051 1:CAS:528:DC%2BD1cXjtl2mu7k%3D 18093835 (Pubitemid 351380929)
16. C Jiang HJ Lee GX Li, et al. 2006 Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer Cancer Res 66 453 463 10.1158/0008-5472.CAN-05-1865 1:CAS:528:DC%2BD28XhsFWlsA%3D%3D 16397261 doi:10.1158/0008-5472.CAN-05-1865 (Pubitemid 43166054)
17. SD Cho C Jiang B Malewicz, et al. 2004 Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription Mol Cancer Ther 3 605 611 1:CAS:528:DC%2BD2cXjvVKntbg%3D 15141018
18. LR Barrows DC Radisky BR Copp, et al. 1993 Makaluvamines, marine natural products, are active anti-cancer agents and DNA topo II inhibitors Anticancer Drug Des 8 333 347 1:CAS:528:DyaK2cXmvV2qtw%3D%3D 8251041
19. DJ Newman GM Cragg 2004 Marine natural products and related compounds in clinical and advanced preclinical trials J Nat Prod 67 1216 1238 10.1021/np040031y 1:CAS:528:DC%2BD2cXkslWhtbo%3D 15332835 doi:10.1021/np040031y (Pubitemid 39145623)
20. TL Simmons E Andrianasolo K McPhail P Flatt WH Gerwick 2005 Marine natural products as anticancer drugs Mol Cancer Ther 4 333 342 1:CAS:528:DC%2BD2MXhtlersrg%3D 15713904
21. T Schlomm L Iwers P Kirstein, et al. 2008 Clinical significance of p53 alterations in surgically treated prostate cancers Mod Pathol 21 1371 1378 10.1038/modpathol.2008.104 1:CAS:528:DC%2BD1cXhsVemt7%2FO 18552821 doi:10.1038/modpathol.2008.104
22. KA Schafer 1998 The cell cycle: a review Vet Pathol 35 461 478 10.1177/030098589803500601 1:CAS:528:DyaK1cXns1SktLk%3D 9823588
23. LL Seville N Shah AD Westwell WC Chan 2005 Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer Curr Cancer Drug Targets 5 159 170 10.2174/1568009053765816 1:CAS:528:DC%2BD2MXksFKktr4%3D 15892617 doi:10.2174/1568009053765816 (Pubitemid 40694858)
24. S Zinkel A Gross E Yang 2006 BCL2 family in DNA damage and cell cycle control Cell Death Differ 13 1351 1359 10.1038/sj.cdd.4401987 1:CAS:528:DC%2BD28XmvFaiur8%3D 16763616 doi:10.1038/sj.cdd.4401987 (Pubitemid 44057470)
25. H Wang P Oliver Z Zhang S Agrawal R Zhang 2003 Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms Ann N Y Acad Sci 1002 217 235 10.1196/annals.1281.025 1:CAS:528:DC%2BD2cXisFKhsLg%3D 14751837 doi:10.1196/annals.1281.025 (Pubitemid 38253344)
26. Z Zhang H Wang M Li ER Rayburn S Agrawal R Zhang 2005 Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway Oncogene 24 7238 7247 10.1038/sj.onc.1208814 1:CAS:528:DC%2BD2MXhtFOjurrK 16170383 doi:10.1038/sj.onc.1208814 (Pubitemid 41679285)
27. Z Zhang R Zhang 2005 p53-independent activities of MDM2 and their relevance to cancer therapy Curr Cancer Drug Targets 5 9 20 10.2174/ 1568009053332618 15720185 doi:10.2174/1568009053332618 (Pubitemid 40321796)
28. L Gaughan IR Logan DE Neal CN Robson 2005 Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation Nucleic Acids Res 33 13 26 10.1093/nar/gki141 1:CAS:528:DC%2BD2MXmsVyisA%3D%3D 15640443 doi:10.1093/nar/gki141 (Pubitemid 40276925)